Unlock instant, AI-driven research and patent intelligence for your innovation.

Antibody, its preparation method and application

An antibody and dimer technology, applied in biochemical equipment and methods, chemical instruments and methods, carriers, etc., can solve problems such as false positives, reduce sensitivity and specificity of clinical applications, affect clinical diagnosis, etc., and achieve production costs low effect

Active Publication Date: 2020-11-03
FUNDAMENTA THERAPEUTICS INC
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the process of clinical detection, they are affected by many factors, which often cause false positive or false negative results, which reduce the sensitivity and specificity of clinical application and directly affect clinical diagnosis.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antibody, its preparation method and application
  • Antibody, its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] The preparation of embodiment one anti-human D-dimer hybridoma cell line

[0036] 1. Animal immunization

[0037] BALB / c female mice (purchased from Changzhou Cavens Experimental Animal Co., Ltd.) were immunized with natural human D-dimer (purchased from Meridian) according to the general immunization procedure. For specific immunization conditions, please refer to the "Experimental Guidelines for Antibody Preparation and Use". The serum titer of immunized mice was tracked by indirect ELISA method, and the immunized mouse with the highest serum titer was selected for fusion experiment of mouse splenocytes and mouse myeloma cells.

[0038] 2. Cell Fusion

[0039] (1) Preparation of spleen cells

[0040] Take the immunized mice, remove their eyeballs, take blood, put them to death by breaking the cervical spine, soak them in 75% (v / v) alcohol for 10 minutes, take out their spleens in a sterile operating table, place them in a cell mesh, and grind the cells fully , pas...

Embodiment 2

[0048] Embodiment two hybridoma cell line antibody variable region sequence determination

[0049] The sequence of the variable region of the antibody of the hybridoma cell line LJ002 was determined.

[0050] (1) Extraction of RNA: According to the instructions of the Total Cell RNA Extraction Kit (purchased from Roche Company), the total RNA of the above-mentioned hybridoma cell line LJ002 was extracted and immediately reverse-transcribed;

[0051] (2) Reverse transcription of RNA into DNA: refer to Thermo Scientific Reverted First strand cDNA Synthesis Kit (purchased from Thermo Company) to reverse transcribe the total RNA extracted in the previous step to obtain cDNA, and freeze it at -20°C for later use ;

[0052] (3) PCR amplification and recovery of the variable region sequence: the cDNA obtained in the above step was used as a template, and the variable region sequence of the mouse IgG subtype monoclonal antibody was used as a primer for the variable region of the heav...

Embodiment 3

[0059] Example 3 The expression vector of anti-D-dimer humanized chimeric antibody was transfected into CHO cells for expression

[0060] Carry out routine DNA recombination operations as described in "Molecular Cloning", clone the variable region of the light chain into pSRNC-Cκ, clone the variable region of the heavy chain into the corresponding site in pSRDC-Cγ1, and construct a complete anti-D-dimerization Eukaryotic expression vector of humanized chimeric antibody gene. CHO cells (preserved in this laboratory) were prepared with 10% FBS, 0.03mmol / l hypoxanthine (H), 0.003mmol / l thymidine (T), 0.1mmol / l proline (Pro), 0.1mmol Glycine (Gly), 100u / ml penicillin, streptomycin 100u / l, 2mmol / l glutamine DMEM complete culture solution in 5% CO2, 37 ° C conditions, routinely according to 1:10 passage, about 3-4 days passed down from generation to generation. The above cell culture reagents were purchased from Gibco. Using the method of gene transfection, Lipofect AMINE reagent...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an antibody as well as a preparation method and application thereof. An amino acid sequence of a heavy chain variable region of the antibody is shown in SEQ ID NO.1 and an amino acid sequence of a light chain variable region of the antibody is shown in SEQ ID NO.2. The sensitivity and specificity of the antibody can meet detection requirements, and the antibody is low in production cost, can be applied to a detection kit on a large scale and has important significance for rapid diagnosis of human diseases at the early stage.

Description

technical field [0001] The invention relates to an antibody, its preparation method and application, and belongs to the field of biotechnology. Background technique [0002] Fibrinogen in the human body is degraded under the action of plasmin produced after the activation of the fibrinolytic system to form Bβ1-42 peptide bonds, A, B, C, H pole appendages and X, Y, D, E fragments, called It is a fibrinogen degradation product (FgDP). [0003] Under the action of thrombin, the fibrinogen α (A) chain and β (B) chain in the human body successively release fibrin peptide A (FPA) and peptide B (FPB), and the rest are called fibrin I ( Fb-I) and fibrin II (Fb-II). Under the action of plasmin, Fb-I is degraded into Bβ1~42 peptide bonds, A, B, C, H extreme appendages and X', Y', D, E' fragments, Fb-II is degraded into Bβ15 ~42 peptide bonds, A, B, C, H pole appendages and X', Y', D, E' fragments; meanwhile, Fb-I and Fb-II can self-polymerize into soluble fibrin monomer polymer (sF...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K16/36C12N15/85G01N33/68
CPCC07K16/36C07K2317/24C07K2317/56C07K2317/565C12N15/85C12N2800/107G01N33/68G01N2333/75
Inventor 李俊张鹏潮
Owner FUNDAMENTA THERAPEUTICS INC